📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Testing alternative schedules of adjuvant immune checkpoint blockers - The need for well-designed clinical trials (2023)

First Author: Bouche G

Attributed to: Evaluating new healthcare technologies in cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ejca.2022.10.024

PubMed Identifier: 36427393

Publication URI: http://europepmc.org/abstract/MED/36427393

Type: Journal Article/Review

Parent Publication: European Journal of Cancer

ISSN: 0959-8049